Citigroup’s Cue Biopharma CUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-43
Closed -$47 4816
2024
Q4
$47 Hold
43
﹤0.01% 4846
2024
Q3
$33 Sell
43
-5,002
-99% -$3.84K ﹤0.01% 4751
2024
Q2
$6.26K Sell
5,045
-1,024
-17% -$1.27K ﹤0.01% 4473
2024
Q1
$11.5K Buy
6,069
+483
+9% +$913 ﹤0.01% 4411
2023
Q4
$14.7K Buy
5,586
+5,551
+15,860% +$14.7K ﹤0.01% 4331
2023
Q3
$80 Sell
35
-10,257
-100% -$23.4K ﹤0.01% 4684
2023
Q2
$37.6K Buy
+10,292
New +$37.6K ﹤0.01% 4106
2022
Q3
Sell
-312
Closed -$1K 5029
2022
Q2
$1K Sell
312
-1,704
-85% -$5.46K ﹤0.01% 5189
2022
Q1
$10K Sell
2,016
-78,169
-97% -$388K ﹤0.01% 4737
2021
Q4
$907K Buy
80,185
+51,980
+184% +$588K ﹤0.01% 2645
2021
Q3
$411K Sell
28,205
-54,920
-66% -$800K ﹤0.01% 3022
2021
Q2
$968K Buy
83,125
+8,888
+12% +$104K ﹤0.01% 2644
2021
Q1
$906K Buy
74,237
+68,248
+1,140% +$833K ﹤0.01% 2453
2020
Q4
$75K Buy
5,989
+3,568
+147% +$44.7K ﹤0.01% 3864
2020
Q3
$36K Sell
2,421
-43,590
-95% -$648K ﹤0.01% 3642
2020
Q2
$1.13M Buy
46,011
+39,942
+658% +$979K ﹤0.01% 2023
2020
Q1
$86K Buy
6,069
+2,005
+49% +$28.4K ﹤0.01% 3390
2019
Q4
$65K Sell
4,064
-10,276
-72% -$164K ﹤0.01% 3799
2019
Q3
$121K Sell
14,340
-2,570
-15% -$21.7K ﹤0.01% 3342
2019
Q2
$152K Buy
16,910
+108
+0.6% +$971 ﹤0.01% 3368
2019
Q1
$130K Sell
16,802
-392
-2% -$3.03K ﹤0.01% 3406
2018
Q4
$80K Sell
17,194
-6,619
-28% -$30.8K ﹤0.01% 3632
2018
Q3
$216K Buy
23,813
+2,313
+11% +$21K ﹤0.01% 3105
2018
Q2
$255K Sell
21,500
-34,564
-62% -$410K ﹤0.01% 2776
2018
Q1
$788K Buy
+56,064
New +$788K ﹤0.01% 1973